期刊文献+

血浆促酰化蛋白在评价儿童肥胖症发展中的意义 被引量:1

Significance of plasma acylation stimulating protein in evaluation of obesity progress in children
原文传递
导出
出处 《中华儿科杂志》 CAS CSCD 北大核心 2005年第2期142-143,共2页 Chinese Journal of Pediatrics
基金 国家自然科学基金(30170442) 国家自然科学基金国际交流与合作项目(30311120163)
  • 相关文献

参考文献5

  • 1Ciaflone K, Roncari DA K, Maslowska M, et al. Adipsin/acylation stimulating protein system in human adipocytes: regulation of triacylglycerol synthesis. Biochemistry, 1994,33 : 489-495.
  • 2Ciardlone K. The acylation stimulating protein pathway: clinical implications. Clin Biochem, 1997, 30: 301-312.
  • 3Murray I, Kohl J, Ciantlone K. Acylation-stimulating protein(ASP) : Structure-function determinants of cell surface binding and triacylglycerol synthetic activity. Biochem J, 1999, 342Pt1 :41-48.
  • 4Ciatlone K, Kalant D, Marliss EB, et al. Response of plasma ASP to a prolonged fast. Intl J Obesity, 1995,19: 604-609.
  • 5Maslowska M, Vu H, Phelis S, et al. Plasma acylation stimulating protein, adiposin and lipids in non-obese and obese populations. Eur J Clin Invest, 1999,29 : 679-686.

同被引文献20

  • 1卢慧玲,王宏伟,Katherine Cianflone,温宇,林汉华.肥胖症儿童血浆脂联素、促酰化蛋白水平变化的临床意义[J].中华内分泌代谢杂志,2004,20(6):499-501. 被引量:7
  • 2米杰,程红,侯冬青,段佳丽,滕红红,王友发.北京市2004年2-18岁儿童青少年超重和肥胖流行现状[J].中华流行病学杂志,2006,27(6):469-474. 被引量:135
  • 3Kuczmarski RJ,Ogden CL,Grummer-Strawn LM,et al.CDC growth charts:United States.Adv Data,2000,(314):1-27.
  • 4Cook S,Weitzman M,Auinger P,et al.Prevalence of a metabolic syndrome phenotype in adolescents:findings from the third National Health and Nutrition Examination Survey,1988-1994.Arch Pediatr Adolesc Med,2003,157(8):821-827.
  • 5Zimmet P,Alberti KG,Kaufman F,et al.The metabolic syndrome in children and adolescents--an IDF consensus report.Pediatr Diabetes,2007,8(5):299-306.
  • 6Weyer C,Tataranni PA,Pratley RE.Insulin action and insulinemia are closely related to the fasting complement C3,but not acylation stimulating protein concentration.Diabetes Care,2000,23(6):779-785.
  • 7Yang Y,Lu HL,Zhang J,et al.Relationships among acylation stimulating protein,adiponectin and complement C3 in lean vs obese type 2 diabetes.Int J Obes (Lond),2006,30(3):439-446.
  • 8Cianflone K,Zhang XJ,Genest J Jr,et al.Plasma acylation-stimulating protein in coronary artery disease.Arterioscler Thromb Vasc Biol,1997,17(7):1239-1244.
  • 9Hernández-Mijares A,Jarabo-Bueno MM,López-Ruiz A,et al.Levels of C3 in patients with severe,morbid and extreme obesity:its relationship to insulin resistance and different cardiovascular risk factors.Int J Obes (Lond),2007,31(6):927-932.
  • 10Onat A,Uzunlar B,Hergenc G,et al.Cross-sectional study of complement C3 as a coronary risk factor among men and women.Clin Sci (Lond),2005,108(2):129-135.

引证文献1

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部